We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
+$9.85M
Cap. Flow
+$95.1M
Cap. Flow %
9.1%
Top 10 Hldgs %
50%
Holding
874
New
223
Increased
214
Reduced
73
Closed
220

Top Buys

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$54.9M
2
IMCR icon
Immunocore
IMCR
+$48.2M
3
ARKK icon
ARK Innovation ETF
ARKK
+$41.6M
4
TWTR
Twitter, Inc.
TWTR
+$36.7M
5
RNAM
Avidity Biosciences
RNAM
+$29.2M

Top Sells

Rank Stock Value
1
RLMD icon
Relmada Therapeutics
RLMD
+$23.6M
2
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
+$19M
3
RBAC
RedBall Acquisition Corp.
RBAC
+$12.5M
4
SMFG icon
Sumitomo Mitsui Financial
SMFG
+$12.1M
5
STOK icon
Stoke Therapeutics
STOK
+$11.8M

Sector Composition

Rank Sector Weight
1 Healthcare 34.11%
2 Financials 8.03%
3 Materials 6.97%
4 Technology 3.58%
5 Industrials 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PACB icon
726
PUT
Pacific Biosciences
PACB
$354M
– –
-5,100
Closed -$8K
PETWW
727
DELISTED
Wag! Group Co Warrant
PETWW
– –
-50,000
Closed -$9K
PINS icon
728
CALL
Pinterest
PINS
$13.4B
– –
-25,000
Closed -$4K
PLTK icon
729
CALL
Playtika
PLTK
$1.02B
– –
-12,500
Closed -$1K
PRENW
730
Prenetics Global Ltd Warrant
PRENW
$113K
– –
-13,555
Closed -$6K
PRG icon
731
PROG Holdings
PRG
$1.66B
– –
-22,500
Closed -$371K
PRG icon
732
PUT
PROG Holdings
PRG
$1.66B
– –
-50,000
Closed -$697K
PROK icon
733
ProKidney
PROK
$330M
– –
-38,248
Closed -$381K
PTGX icon
734
Protagonist Therapeutics
PTGX
$9.6B
– –
-1,065,724
Closed -$8.43M
QQQ icon
735
CALL
Invesco QQQ Trust
QQQ
$478B
– –
-19,000
Closed -$63K
QQQ icon
736
PUT
Invesco QQQ Trust
QQQ
$478B
– –
-17,500
Closed -$355K
SG icon
737
CALL
Sweetgreen
SG
$642M
– –
-20,000
Closed -$25K
SGHC icon
738
SGHC Ltd
SGHC
$6.59B
– –
-50,000
Closed -$205K
SLND.WS icon
739
Southland Holdings Warrants
SLND.WS
$1.48M
– –
-57,153
Closed -$15K
SMH icon
740
CALL
VanEck Semiconductor ETF
SMH
$70.6B
– –
-30,000
Closed -$22K
SMH icon
741
PUT
VanEck Semiconductor ETF
SMH
$70.6B
– –
-45,000
Closed -$216K
SNAP icon
742
CALL
Snap
SNAP
$9.32B
– –
-58,500
Closed -$24K
SPY icon
743
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$807B
– –
-11,400
Closed -$61K
SPY icon
744
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$807B
– –
-10,000
Closed -$55K
TBLA icon
745
Taboola.com
TBLA
$1.11B
– –
-144,910
Closed -$367K
TEVA icon
746
CALL
Teva Pharmaceuticals
TEVA
$42.5B
– –
-223,800
Closed -$94K
TGT icon
747
CALL
Target
TGT
$69.2B
– –
-19,700
Closed -$7K
TGT icon
748
PUT
Target
TGT
$69.2B
– –
-24,900
Closed -$2.37M
TGTX icon
749
CALL
TG Therapeutics
TGTX
$7.64B
– –
-112,000
Closed -$76K
TTWO icon
750
CALL
Take-Two Interactive
TTWO
$46.8B
– –
-152,800
Closed -$22K
28 29
30
31 32

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2022 Portfolio in Review

As of Q3 2022, Cowen and Company held 874 positions worth $1.05B, up 0.95% from $1.04B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Cowen and Company deployed $95.1M of net new capital in Q3 2022, opening 223 new positions and adding to 214 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Relmada Therapeutics, an estimated $23.6M trimmed.

  • Cowen and Company's largest Q3 2022 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.
  • Cowen and Company added most to ARK Innovation ETF in Q3 2022, an estimated $41.6M increase.
  • Cowen and Company's biggest Q3 2022 reduction was Relmada Therapeutics, cutting an estimated $23.6M.
  • Cowen and Company fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $19M.
  • Cowen and Company's ten largest holdings make up 50% of its $1.05B portfolio in Q3 2022.
  • Cowen and Company opened 223 new positions and closed 220 in Q3 2022.
  • Cowen and Company's portfolio value rose 0.95% quarter-over-quarter to $1.05B.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.